Error loading player: No playable sources found

Player size: small large

To view this video content in its entirety, click on the "Access Content" button and login to your account.

If you do not have an account, register for free.

Please note that the account you create here is different than your Keystone Symposia account at www.keystonesymposia.org used to register for our multi-day conferences and is uniquely for viewing our virtual content.

HIV/AIDS: Strategies for an Endgame

Free

Standard Price

This product is also available as part of the following products:

On Demand

Keystone Symposia LivePanel:

HIV/AIDS: Strategies for an Endgame

Broadcast live on December 13, 2013, this 90-minute interactive webcast featured a panel of five experts in the HIV/AIDS research field. Discussion focused on several key areas:

What is the quickest, most effective way to end the AIDS epidemic?
How should priorities be determined for different strategies — in particular, pre-exposure prophylaxis and vaccines?
What are the merits of each of these approaches that make it the optimal strategy?

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

Moderator

Bruce D. Walker, MD

Ragon Institute of MGH, MIT and Harvard

Panelists

Myron S. Cohen, MD

University of North Carolina at Chapel Hill

Betsy Herold, MD

Albert Einstein College of Medicine

Julie McElrath, MD, PhD

Fred Hutchinson Cancer Research Center (FHCRC)

Gary Nabel, MD, PhD

Sanofi

General

ePanel | Infectious Disease | HIV | education

Specialties

Related Products

Thumbnail for Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain

Deciphering the molecular basis of unusually high neutralization resistance in a tier 3 HIV-1 strain

DECIPHERING THE MOLECULAR BASIS OF UNUSUALLY HIGH NEUTRALIZATION RESISTANCE IN A TIER 3 HIV-1 STRAIN

Thumbnail for Training Next-Gen Underrepresented (UR) Biomedical Scientists: What Works, What’s Wrong, What’s Right on Target

Training Next-Gen Underrepresented (UR) Biomedical Scientists: What Works, What’s Wrong, What’s Right on Target

In today’s climate of tense identity politics, race and gender issues remain hot topics that we, as a nation, grapple with every day…

Thumbnail for Mosquito-Borne Diseases: From Long Time Foes to Emerging Threats

Mosquito-Borne Diseases: From Long Time Foes to Emerging Threats

Arboviruses are a large group of viruses transmitted by insects such as mosquitos and ticks…

Thumbnail for Health Disparities: Sickle Cell, Research and CRISPR

Health Disparities: Sickle Cell, Research and CRISPR

About 100,000 people in the United States have sickle cell disease, with most of the patient population derived from communities of African descent…

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.